CNS5:Diffuse hemispheric glioma, H3 G34-mutant: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| Line 439: | Line 439: | ||
*DNA methylation and gene expression profiling can be used to differentiate G34-DHG with other glioma subgroups. | *DNA methylation and gene expression profiling can be used to differentiate G34-DHG with other glioma subgroups. | ||
*''MGMT'' promoter methylation can be assessed by methylation specific polymerase chain reaction analysis (bisulfite treated DNA undergoes real-time PCR)<br /> | *''MGMT'' promoter methylation can be assessed by methylation specific polymerase chain reaction analysis (bisulfite treated DNA undergoes real-time PCR)<br /> | ||
== Familial Forms == | |||
N/A | |||
== Additional Information == | |||
This disease is <u>defined/characterized</u> as detailed below: | |||
The <u>epidemiology/prevalence</u> of this disease is detailed below: | |||
The <u>clinical features</u> of this disease are detailed below: | |||
Signs and symptoms - | |||
Laboratory findings - | |||
The <u>sites of involvement</u> of this disease are detailed below: | |||
The <u>morphologic features</u> of this disease are detailed below: | |||
The <u>immunophenotype</u> of this disease is detailed below: | |||
Positive (universal) - | |||
Positive (majority) - | |||
Positive (subset) - | |||
Negative (universal) - | |||
Negative (subset) - | |||
== Links == | |||
None | |||
==References== | ==References== | ||